MarketWatch Automation
Shares of Regeneron Pharmaceuticals Inc. /zigman2/quotes/203149337/composite REGN +0.54% slid 3.74% to $599.77 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.07% falling 3.20% to 3,991.24 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.27% falling 1.99% to 32,245.70. This was the stock's third consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $147.65 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.03% rose 0.54% to $177.33, Novartis AG ADR /zigman2/quotes/203243705/composite NVS +0.71% fell 2.73% to $83.48, and Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.79% rose 1.16% to $239.24. Trading volume (818,064) eclipsed its 50-day average volume of 648,090.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Add to watchlist
REGN
Add to watchlist
DJIA
Add to watchlist
JNJ
Add to watchlist
NVS
Add to watchlist
AMGN
